Image is an illustration, may not reflect the exact product sold.


Other products by Merck

Merck - 69956-3 - 69956-3, BLR(DE3)pLysS Competent Cells - Novagen BLR is a recA derivative of BL21 that improves plasmid monomer yields and may help stabilize target plasmids containing repetitive sequences. T7 lysozyme expression suppresses basal T7

  • MFR SKU: 69956-3
  • ITEM #: 3441045
    • 0 out of 5 stars
    • 5 Star
      0 %
    • 4 Star
      0 %
    • 3 Star
      0 %
    • 2 Star
      0 %
    • 1 Star
      0 %
  • 0 Reviews / 0 Questions
$185.95

  • Please complete this captcha to continue

Stock Status: SHIPS SOON (reserve your unit today)
Average lead time for this brand: 2-3 weeks. Specific products may vary.

  • Please complete this captcha to continue

    * Please log into your account to avoid entering this information every time.


ITEM #: 3441045
Genotype: F-ompT hsdSB(rB- mB-) gal dcm (DE3) Delta(srl-recA)306::Tn10 pLysS (CamR, TetR)This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD)...
ITEM #: 3441045
Genotype: F-ompT hsdSB(rB- mB-) gal dcm (DE3) Delta(srl-recA)306::Tn10 pLysS (CamR, TetR)This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
: NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes: 1. A. Roca (U. of Wisconsin), personal communication.2. Studier, F. W. (1991) J. Mol. Biol. 219, 37-44.
69956-3, BLR(DE3)pLysS Competent Cells - Novagen BLR is a recA derivative of BL21 that improves plasmid monomer yields and may help stabilize target plasmids containing repetitive sequences. T7 lysozyme expression suppresses basal T7 expression.
This listing is for Each
Read More >>

Merck - 69956-3 - 69956-3, BLR(DE3)pLysS Competent Cells - Novagen BLR is a recA derivative of BL21 that improves plasmid monomer yields and may help stabilize target plasmids containing repetitive sequences. T7 lysozyme expression suppresses basal T7

  • Item #: 3441045
  • MFR SKU: 69956-3
Technical Specs
  • Overview BLR is a recA - derivative of BL21 that improves plasmid monomer yields and may help stabilize target plasmids containing repetitive sequences or whose products may cause the loss of the DE3 prophage (1, 2).
  • DE3 indicates that the host is a lysogen of λ DE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene under control of the lacUV5 promoter. Such strains are suitable for production of protein from target genes cloned in pET vectors by induction with IPTG.
  • pLysS strains express T7 lysozyme, which further suppresses basal expression of T7 RNA polymerase prior to induction, thus stabilizing pET recombinants encoding target proteins that affect cell growth and viability.
  • Genotype: F - ompT hsdS B (r B - m B - ) gal dcm (DE3) Δ(srl-recA)306 ::Tn 10 pLysS (Cam R , Tet R )
  • This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
  • This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@ .
  • Catalogue Number 69956
  • Brand Family Novagen®
  • References 1. A. Roca (U. of Wisconsin), personal
  • communication.
  • 2. Studier, F. W. (1991) J. Mol. Biol . 219 ,
  • 37-44.
  • Components
  • Guaranteed efficiency Guaranteed efficiency: > 2 x 10 cfu/μg
  • Quality Level MQ100
  • Ship Code Dry Ice Only
  • Toxicity Multiple Toxicity Values, refer to MSDS
  • Storage ≤ -70° C
  • Avoid freeze/thaw Avoid freeze/thaw
  • Do not freeze Ok to freeze
Questions & Answers

There are no questions about this product yet. Be the first to ask a question.

Add Question
0 Customer Ratings & Reviews
0 out of 5 stars
5 Star
0 %
4 Star
0 %
3 Star
0 %
2 Star
0 %
1 Star
0 %

Review this product

Tell us about your personal experience

Write a review

Recently Viewed Items